Rosen, national trial counsel, encourages aquestive therapeutics, inc. investors with losses in excess of $100k to secure counsel before important deadline - aqst

New york, march 17, 2021 /prnewswire/ --   why: rosen law firm, a global investor rights law firm, reminds purchasers of the securities of aquestive therapeutics, inc. (nasdaq: aqst) between december 2, 2019 and september 25, 2020, inclusive (the "class period"), of the important april 30, 2021 lead plaintiff deadline. so what: if you purchased aquestive securities during the class period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
AQST Ratings Summary
AQST Quant Ranking